MICHELLE KAMAN: Open Payments
NPI 1518338391 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 66 payments from 24 companies in 2025. Trend: 2023 $1,346 · 2024 $1,119 · 2025 $1,248
Food & beverage: $1,248
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 16 | $238 |
| Novo Nordisk Inc | 7 | $152 |
| PFIZER INC. | 7 | $142 |
| Lilly USA, LLC | 4 | $85 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $84 |
| ABBVIE INC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Boston Scientific Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
Products named: Korlym, ELIQUIS, Ozempic, ISTURISA, QULIPTA, Rybelsus, LEQVIO, JARDIANCE.
Industry payments across FL — which companies pay providers there.
